Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 4.


Attard, Gerhardt, Murphy, Laura, Clarke, Noel W, Cross, William, Jones, Robert J ORCID: 0000-0001-5608-001X, Parker, Christopher C, Gillessen, Silke, Cook, Adrian, Brawley, Chris, Amos, Claire L
et al (show 38 more authors) (2022) Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. LANCET, 399 (10323). pp. 447-460.


James, Nicholas D, Clarke, Noel W, Cook, Adrian, Ali, Adnan, Hoyle, Alex P, Attard, Gerhardt, Brawley, Christopher D, Chowdhury, Simon, Cross, William R, Dearnaley, David P
et al (show 46 more authors) (2022) Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476). INTERNATIONAL JOURNAL OF CANCER, 151 (3). pp. 422-434.


Clarke, Caroline S, Hunter, Rachael M, Gabrio, Andrea, Brawley, Christopher D, Ingleby, Fiona C, Dearnaley, David P, Matheson, David, Attard, Gerhardt, Rush, Hannah L, Jones, Rob J ORCID: 0000-0001-5608-001X
et al (show 12 more authors) (2022) Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data. PloS one, 17 (6). e0269192-e0269192.


Hussain, Syed A, Palmeri, Daniel H, Syn, Wing-Kin, Sacco, Joseph J, Greensmith, Richard MD, Elmetwali, Taha, Aachi, Vijay, Lloyd, Bryony H, Jithesh, Puthen V, Arrand, John
et al (show 4 more authors) (2017) Gene expression profiling in bladder cancer identifies potential therapeutic targets. INTERNATIONAL JOURNAL OF ONCOLOGY, 50 (4). pp. 1147-1159.

This list was generated on Mon Jan 15 22:05:07 2024 GMT.